Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosis (Q24294760)

somatic stem cell population maintenance

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

1 reference

1 reference

5

0 references

Xavier Leleu

10

Catherine Roche-Lestienne

Xavier Leleu

0 references

2

Catherine Roche-Lestienne

0 references

Christophe Desterke

4

Christophe Desterke

0 references

Joris Andrieux

1

Joris Andrieux

0 references

author name string

Sandrine Geffroy

3

0 references

Isabelle Plantier

6

0 references

Dominik Selleslag

7

0 references

Jean-Loup Demory

8

0 references

Jean-Luc Laï

9

0 references

Caroline Le Bousse-Kerdiles

11

0 references

Peter Vandenberghe

Cancer Genetics and Cytogenetics

12

0 references

language of work or name

English

0 references

publication date

1 October 2007

0 references

published in

0 references

volume

178

0 references

issue

1

0 references

page(s)

11-6

0 references

cites work

Identification of three novel mutations of the noggin gene in patients with fibrodysplasia ossificans progressiva

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANCERGENCYTO.2007.06.001

7 January 2021

TGF beta/Smad signaling system and its pathologic correlates

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANCERGENCYTO.2007.06.001

7 January 2021

Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANCERGENCYTO.2007.06.001

7 January 2021

Lineage-restricted expression of bone morphogenetic protein genes in human hematopoietic cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANCERGENCYTO.2007.06.001

7 January 2021

Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANCERGENCYTO.2007.06.001

7 January 2021

Localization of bone morphogenetic proteins (BMPs)-2, -4, and -6 within megakaryocytes and platelets

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANCERGENCYTO.2007.06.001

7 January 2021

Frequency of structural abnormalities of the long arm of chromosome 12 in myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANCERGENCYTO.2007.06.001

7 January 2021

Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANCERGENCYTO.2007.06.001

7 January 2021

Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANCERGENCYTO.2007.06.001

7 January 2021

Stem cell dysregulation in myelofibrosis with myeloid metaplasia: current data on growth factor and transcription factor involvement

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANCERGENCYTO.2007.06.001

7 January 2021

Human disease-causing NOG missense mutations: effects on noggin secretion, dimer formation, and bone morphogenetic protein binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANCERGENCYTO.2007.06.001

7 January 2021

Characterization of a stapes ankylosis family with a NOG mutation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANCERGENCYTO.2007.06.001

7 January 2021

Role of bovine bone morphogenetic proteins in bone matrix protein and osteoblast-related gene expression during rat bone marrow stromal cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANCERGENCYTO.2007.06.001

7 January 2021

Pathogenesis of idiopathic myelofibrosis: role of growth factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANCERGENCYTO.2007.06.001

7 January 2021

Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANCERGENCYTO.2007.06.001

7 January 2021

Pathogenesis of myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANCERGENCYTO.2007.06.001

7 January 2021

Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANCERGENCYTO.2007.06.001

7 January 2021

Skeletal Overexpression of Noggin Results in Osteopenia and Reduced Bone Formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANCERGENCYTO.2007.06.001

7 January 2021

Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANCERGENCYTO.2007.06.001

7 January 2021

In vivo somatic cell gene transfer of an engineered Noggin mutein prevents BMP4-induced heterotopic ossification

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANCERGENCYTO.2007.06.001

7 January 2021

TM4: a free, open-source system for microarray data management and analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANCERGENCYTO.2007.06.001

7 January 2021

Acute myelofibrosis. An accelerated variant of agnogenic myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CANCERGENCYTO.2007.06.001

7 January 2021